Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eilon Barnea

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Molecular & Cellular Proteomics : MCP|February 12, 2017
The Human Leukocyte Antigen (HLA)-B27 Peptidome <i>in Vivo</i>, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 DeletionEilon Barnea, Dganit Melamed Kadosh, Yael Haimovich, et al.
Molecular & Cellular Proteomics : MCP|May 27, 2020
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in MouseNataly Mancette Rijensky, Netta R Blondheim Shraga, Eilon Barnea, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Nature Biotechnology|October 6, 2022
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumorsAssaf Kacen, Aaron Javitt, Matthias P Kramer, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Molecular & Cellular Proteomics : MCP|February 12, 2017
The Human Leukocyte Antigen (HLA)-B27 Peptidome <i>in Vivo</i>, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 DeletionEilon Barnea, Dganit Melamed Kadosh, Yael Haimovich, et al.
Molecular & Cellular Proteomics : MCP|May 27, 2020
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in MouseNataly Mancette Rijensky, Netta R Blondheim Shraga, Eilon Barnea, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Nature Biotechnology|October 6, 2022
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumorsAssaf Kacen, Aaron Javitt, Matthias P Kramer, et al.
Cell|September 17, 2019
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaYochai Wolf, Osnat Bartok, Sushant Patkar, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaBracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Pageof 7